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Abstract
Objectives—We sought to identify characteristics of parents who believe in sexual disinhibition
and that Pap smears can safely be stopped after females receive HPV vaccine.
Methods—We surveyed 647 parents of adolescent girls living in areas of North Carolina with
elevated rates of cervical cancer. We report data primarily from a survey conducted in Fall 2008.
Results—Only 16% (101/647) of parents agreed that teenage girls who receive HPV vaccine
may be more likely to have sex. Parents who believed in vaccine-induced sexual disinhibition
were more likely to be older (OR 1.89; 95% CI 1.09, 3.26) or report conservative political views
(OR 2.26; 95% CI 1.37, 3.73). Parents were less likely to believe in sexual disinhibition if they
had greater knowledge about HPV vaccine (OR 0.52; 95% CI 0.32 0.85) or if their daughters had
received HPV vaccine (OR 0.31; 95% CI 0.17, 0.57). While few parents (5%, 30/647) believed
that women could safely stop getting regular Pap smears after receiving HPV vaccine, this belief
was somewhat more common among racial and ethnic minority parents (16%) and among fathers
(13%).
Conclusions—Few parents believed that HPV vaccine is likely to lead to increased sexual
activity among females or reduce the need for vaccinated women to have regular Pap smears in the
future. Characterizing parents who hold beliefs in behavioral disinhibition is important as
clinicians encountering parents in practice may desire information about this population.
Correspondence and requests for reprints should be sent to: Paul L. Reiter, PhD, University of North Carolina Gillings School of
Global Public Health, Department of Health Behavior and Health Education, 323D Rosenau Hall, CB 7440, Chapel Hill, NC
27599-7440, Tel: 919-966-8650, Fax: 919-966-2921, preiter@email.unc.edu. Second corresponding author: Noel T. Brewer, PhD,
UNC Gillings School of Global Public Health, Department of Health Behavior and Health Education, 325 Rosenau Hall, CB 7440,
Chapel Hill, NC 27599-7440, ntb1@unc.edu.
Author Contributions
C.L. Schuler performed the data analysis and wrote the initial manuscript draft. P.L. Reiter assisted with and provided guidance for
data analysis and the writing process. J.S. Smith provided guidance for the data analysis and writing process. N.T. Brewer conceived
of the study, supervised its implementation, provided guidance, and assisted with the writing. All authors helped to conceptualize
ideas, interpret findings, and review drafts of the manuscript.
Competing interests and Funding:
Although we do not believe we have any conflicts of interest, we wish to share the following information in the interest of full
disclosure.
Copyright License Statement:
The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence
(or non exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if
accepted) to be published in STI and any other BMJPGL products and sub-licences such use and exploit all subsidiary rights, as set
out in our licence http://group.bmj.com/products/journals/instructions-for-authors/licence-forms.
NIH Public Access
Author Manuscript
Sex Transm Infect. Author manuscript; available in PMC 2012 June 1.
Published in final edited form as:














risk compensation; risk homeostasis; HPV vaccine; cervical cancer; screening
INTRODUCTION
Prophylactic human papillomavirus (HPV) vaccines are one of the most promising new
tools in the battle against cervical cancer. The US and many other countries have licensed
vaccines to prevent infection with HPV types that cause the majority (>70%) of cervical
cancers.[1] Despite the promise of current generation HPV vaccines, concern that girls
receiving it may become more sexually active [2] has undermined discussions of the merits
of widespread vaccine provision.[3,4] Vaccination leading to increases in sexual behavior is
an example of a class of hypothesized phenomena known as behavioral disinhibition.[5,6]
Another type of potential behavioral disinhibition would be failure to continue protective
health measures, such as regular Pap smear testing, after HPV vaccination.[5]
Although belief in HPV vaccine-induced sexual disinhibition appears to be rare [2], it may
be problematic, as parental concerns about this issue are correlated with decreased interest in
vaccinating daughters against HPV.[7–12] Parents’ beliefs in a reduced need for continued
cervical cancer screening after HPV vaccination would be particularly important, if such
beliefs lowered adherence to screening recommendations. This potential problem would be
especially concerning if it affected populations at elevated risk for cervical cancer, including
African Americans, Hispanics [13], and impoverished women.[14] While parents’ beliefs in
sexual disinhibition have been examined as a barrier to HPV vaccination [7–12,15–18], we
know little about parents who hold such beliefs.[19,20] Furthermore, no studies we are
aware of have explored correlates of parents’ beliefs about the need for cervical cancer
screening after HPV vaccine.
Our study sought to identify characteristics of parents who believed HPV vaccine leads to
increased sexual behavior and reduced need for regular Pap smear testing. Given that the
concerns voiced in the media about behavioral disinhibition have come largely from social
or religious conservatives [3,4], we hypothesized that people who hold more conservative
political and religious views may be more likely to endorse beliefs in sexual disinhibition.
Those with lower knowledge of HPV vaccine may also be more likely to believe in
behavioral disinhibition following HPV vaccination.
METHODS
Study Design
Data are from the Carolina HPV Immunization Measurement and Evaluation (CHIME)
Project that examined HPV vaccine decision making in an area with an elevated rate of
invasive cervical cancer. The CHIME Project interviewed caregivers of adolescent girls
aged 10–18 years as part of a longitudinal study described previously.[21,22] We selected
five counties in southeastern North Carolina that had 1) high cervical cancer rates (incidence
>10 cases/100,000 women annually from 1993–2003 and mortality > 4 deaths/100,000
women annually from 1994–2004); 2) ≥20% African American residents; and 3) ≥1,500
girls in the targeted age range of 10–18 years old. One selected county was urban, and the
four others were rural.
Trained staff conducted phone interviews using computer-assisted telephone equipment with
caregivers in households identified primarily through a non-overlapping targeted list frame
of directory-listed residential telephone numbers with available recent household
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demographic information (95%) or random-digit-dialing (5%). We oversampled households
likely to include an adolescent aged 10–18 years and African American households, as well
as rural telephone exchanges.[22] Households containing at least one female child aged 10–
18 years were eligible to participate. For households that contained more than one female
child in the targeted age range, software randomly chose one child as the index child for the
interviews. Staff interviewed individuals who self-identified as parents, grandparents, or
another caregiver responsible for the index child. Staff attempted to interview female
caregivers, but interviewed male caregivers if a female caregiver was unavailable.[21,22] As
most (97%) caregivers were parents, we subsequently refer to respondents as parents.
Of the 1220 eligible parents, 889 (73%) completed baseline interviews between July and
October 2007.[22] Staff conducted follow-up interviews in October and November 2008
with 650 (74%) of the 873 parents who agreed to be recontacted.[21] We excluded data for
three parents who prematurely ended their follow-up interviews, resulting in an analytic
sample of 647 parents. All participants provided verbal consent for the study and received
$10 for completing each interview. The University of North Carolina Institutional Review
Board approved the study.
Measures
Outcomes—The follow-up survey assessed belief that sexual disinhibition would occur
after HPV vaccination: “If a teenage girl gets the HPV vaccine, she may be more likely to
have sex.” Response options were “strongly disagree,” “somewhat disagree,” “somewhat
agree,” and “strongly agree.” As the distribution of responses was skewed, we dichotomized
responses into “agree” (responded “strongly agree” or “somewhat agree”) and “did not
agree” (other responses).
The survey assessed agreement with a statement regarding cervical cancer screening
disinhibition: “Do you think a woman can safely stop getting regular Pap smears after
getting the HPV vaccine?” Response options were “yes,” “no,” or “I don’t know.” We coded
responses of “no” as correct and other responses as incorrect.
Correlates—The survey assessed characteristics of the daughter, parent, and household
(Table 1). The survey assessed knowledge about HPV vaccine using a 4-question index
(HPV vaccine prevents most cervical cancers, there is an HPV vaccine that can prevent most
genital warts, health officials recommend that all 11–12 year old girls should get the HPV
vaccine, and HPV vaccine works best if girls get it before they start having sex). We
classified parents as having “low HPV vaccine knowledge” (0–2 questions answered
correctly) or “high HPV vaccine knowledge” (3–4 questions answered correctly). Items
assessed parents’ perceived likelihood that their daughters will get HPV infection (1 item) or
cervical cancer (1 item), with each item accompanied by a 4-point response scale ranging
from “no chance” to “high chance” (coded 1–4).
The survey used subscales from the Carolina HPV Immunization Attitudes and Beliefs Scale
(CHIAS) [23] to assess perceived effectiveness of HPV vaccine (2 items) and perceived
barriers to getting daughters vaccinated (5 items). Perceived effectiveness items had 4-point
response scales that ranged from “slightly” to “extremely” (coded 1–4). Four of the
perceived barriers items had response options of “not hard at all” (coded as 1), “somewhat
hard” (coded as 2.5), and “very hard” (coded as 4), and the fifth barrier item had a 4-point
response scale ranging from “strongly disagree” to “strongly agree” (coded 1–4).
The follow-up survey assessed all measures, except as noted. The baseline survey assessed
perceived barriers to HPV vaccination, perceived effectiveness of HPV vaccine, and some
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demographic characteristics including household urbanicity based on the census block
where the parent lived.[24]
Data Analysis
The main outcomes were parents’ beliefs that HPV vaccination may leads to sexual
disinhibition and decreases the need for future regular Pap smear testing. We first examined
bivariate associations of potential correlates with each outcome using logistic regression.
For each outcome, we then constructed a multivariate logistic regression model that included
variables statistically significant in bivariate analyses (p<0.05). We performed analyses
using unweighted data in SPSS 18 (Chicago, IL). Statistical tests were two-tailed and used a
critical alpha of 0.05.
RESULTS
Most parents were 40–49 years of age (59%) and non-Hispanic white (74%). Many parents
identified as born-again or evangelical Christians (65%) and reported conservative political
views (57%). More than one third of respondents believed their daughters may be sexually
active or might become sexually active in the next year (34%), and 16% of parents believed
their daughters were already sexually active or will be in the next year (Table 1).
Belief in Sexual Disinhibition
Only 16% (101/647) of parents agreed that girls receiving HPV vaccine may be more likely
to have sex: 4% (27/647) of parents indicated “strongly agree” and 11% (74/647) indicated
“somewhat agree.” In multivariate analyses, parents who believed in sexual disinhibition
were more likely to be aged 50 years and older (compared to those aged 40–49 years) (OR
1.89; 95% CI 1.09, 3.26) or to report conservative political views (OR 2.26; 95% CI 1.37,
3.73) (Table 1). Parents were less likely to believe in sexual disinhibition if they had higher
knowledge about HPV vaccine (OR 0.52; 95% CI 0.32 0.85) or if their daughters had
received one or more doses of HPV vaccine (OR 0.31; 95% CI 0.17, 0.57). Belief in sexual
disinhibition was more common among born-again Christian parents and parents who
perceived HPV vaccine to be less effective, in bivariate analysis. Neither of these
associations was statistically significant in multivariate analyses.
Belief in Need for Pap Smear Screening
Few parents (5%, 30/647) believed that women could stop getting regular Pap smears after
getting HPV vaccine, and thus we consider these analyses to be exploratory. Fewer non-
Hispanic white parents (17/479, 4%) and non-Hispanic African American parents (7/131,
5%) answered the question incorrectly compared to parents of other racial and ethnic groups
(6/37, 16%). Additionally, more male parents (5/38, 13%) compared to female parents
(25/609, 4%) believed that regular Pap smears are unnecessary after HPV vaccination.
These associations remained statistically significant in multivariate analyses, as parents of
other racial and ethnic groups (compared to non-Hispanic white, OR 5.00; 95% CI 1.81,
13.77) and male parents (OR 3.41; 95% CI 1.19, 9.78 versus female parents) were more
likely to believe that vaccinating eliminates the need for future regular Pap smears. Parents
of other races and ethnicities were also more likely to believe regular Pap testing was no
longer needed compared to non-Hispanic African American parents; this association was not
statistically significant in multivariate analyses (OR=3.04; 95% CI 0.94 to 9.88; p=0.06).
Analyses identified no other associations with potential correlates.
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Belief that HPV vaccination may promote risky behaviors was rare among North Carolina
parents who completed baseline and follow-up interview for the CHIME Project. Older
parents and those with conservative political views were more likely to believe in sexual
disinhibition, while parents with greater vaccine knowledge or whose daughters had
received at least one dose of HPV vaccine were less likely to hold this belief. Belief that
regular Pap smears are unnecessary after HPV vaccination was infrequent. This is consistent
with past research showing that most adult women and parents recognized the need for Pap
smear screening after HPV vaccination.[25,26] However, belief that Pap smears may safely
be stopped was somewhat more common among male parents and those from minority racial
and ethnic groups.
Only 16% of parents in our study agreed that HPV vaccination could increase sexual
behavior in girls. The proportion of parents we found who held this belief is consistent with
previous studies, where estimates ranged from 6–12% before HPV vaccine licensure and as
high as about 30% in more recent studies.[2,19,20,25,27] Taken together, these estimates
suggest some variability in sexual disinhibition beliefs and that they may be changing over
time.
While behavioral disinhibition has been studied extensively without clear conclusions in
fields as diverse as safety belts [28,29]and HIV medications [30], behavioral changes after
HPV vaccination have been studied only hypothetically and remain unproven.[5,19]
Researchers should empirically examine whether HPV vaccination affects sexual behavior
and cervical cancer screening habits, an area currently unexplored. High quality longitudinal
studies comparing vaccinated and unvaccinated females on these behaviors would provide
valuable evidence. If such research were to show no compensatory changes in behavior after
vaccination, these data could allow policymakers and public health officials to refocus their
concerns on cervical cancer prevention. However, if future studies were to indicate behavior
change following vaccination, increasing communication about current guidelines for
continued screening after HPV vaccine takes on special importance.
Our findings suggest political conservatism, but not religion, drives concerns about sexual
disinhibition. While born-again Christians were more likely to believe HPV vaccine may
encourage sexual activity in bivariate analyses, controlling for political leaning eliminated
the association. The association between political conservativeness and belief in sexual
disinhibition remained statistically significant in the multivariate model. Born-again
Christians may not be highly concerned about sexual disinhibition if they believe their
daughters will not be sexually active until marriage, regardless of vaccination, possibly
explaining the lack of a multivariate association. Belief in sexual disinhibition was also
more common among older parents. Previous studies have reported similar or null findings
for the association between parent age and belief in disinhibition.[19,20]
A reasonable question is whether we have correctly conceptualized the relationship between
disinhibition beliefs and HPV vaccination. Although concerns about sexual disinhibition are
associated with reluctance to vaccinate in cross-sectional and qualitative studies [7–12], our
longitudinal study found that parents’ beliefs at baseline about sexual disinhibition and other
potential harms did not predict initiating HPV vaccination for their daughters in the 14
months that followed.[21] Thus, we think that disinhibition beliefs are not a motivator of
vaccine uptake. Instead, we believe the opposite is more likely the case. Parents who get
HPV vaccine for their daughters may justify their actions by giving less credence to sexual
disinhibition concerns.[31] This conceptualization is congruent with our finding that parents
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with vaccinated daughters were less likely to believe in sexual disinhibition, but we will
need to confirm these cross-sectional findings using longitudinal data.
Parents with greater knowledge of HPV vaccine were less likely to believe in sexual
disinhibition. These parents may have had better access to educational materials on HPV
vaccines that may have also helped dispel myths about HPV vaccine. Given that males tend
to have poorer knowledge of HPV than females [32,33], it is not surprising that a lower
proportion of the fathers answered correctly about the need for Pap smears after HPV
vaccination. Considering more parents from minority racial and ethnic groups also held this
belief, educational programs targeted to men and minority parents may be warranted.
Initiatives to educate the public on the need for continued cervical cancer screening are
especially important given that the current generation HPV vaccines do not provide
protection against all carcinogenic HPV types.
Strengths of our study include a wide range of potential correlates examined and a study
design that oversampled African American households and rural telephone exchanges.
However, our study included parents from only one geographic area who spoke English, and
the majority of parents self-identified as born-again or evangelical Christians. As surveys
were by phone, our findings may not represent segments of the population without a landline
telephone. Recent research suggests that bias from this source is likely minimal in surveys of
the general adult population, but it may be more substantial in surveys of younger or
impoverished adults.[34] We were also unable to conduct follow-up interviews with about a
quarter of parents who agreed to be recontacted. Given our study population and potential
study limitations, future studies are needed to establish the generalizability of our findings.
Debates regarding HPV vaccine have focused on concerns about sexual disinhibition,
whether to require the vaccine for school admittance [35], and cost-effectiveness, but they
have missed some issues that concern many parents. Clinicians should be prepared to
discuss common concerns about HPV vaccine, including whether the vaccine is unusually
painful or causes fainting [36], but they should also be aware they are unlikely to encounter
many parents concerned with sexual disinhibition after HPV vaccination. Although parent
concern about increased sexual behavior is rarely the primary reason limiting HPV vaccine
uptake [21], better understanding parents who hold such beliefs may allow physicians to
work more effectively with families to improve vaccine uptake and policy makers to pursue
the ultimate goal of HPV disease prevention more efficiently. Future research is needed to
further explore behavioral disinhibition following HPV vaccination and beliefs about such
disinhibition among other populations.
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